A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control.
about
Viral markers for HIV cure trials: are we getting any closer?Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5-8 Days.Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruptionLong-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral ReactivationInternational AIDS Society global scientific strategy: towards an HIV cure 2016.Post-Treatment Controllers: Role in HIV "Cure" Research."We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry.Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.Treatment interruption after 2-year antiretroviral treatment initiated during acute/early HIV in infancy.Brief Report: Prevalence of Posttreatment Controller Phenotype Is Rare in HIV-Infected Persons After Stopping Antiretroviral Therapy.Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease Inhibitors.Modeling of Antilatency Treatment in HIV: What Is the Optimal Duration of Antiretroviral Therapy-Free HIV Remission?Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells.Wake me up before you go: A strategy to reduce the latent HIV reservoir.Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained.Total HIV DNA: a global marker of HIV persistence.Antiretroviral therapy interruptions: impact on HIV treatment and transmission.HIV control: Is getting there the same as staying there?
P2860
Q26740038-1262B871-6B3D-4B1F-B97A-E048A3EEC151Q31123548-A543DC65-6872-49A4-9B9D-6A7D5CF1E0F1Q36758540-546C0CD7-E598-4D8E-AC5C-39367BAA4AA3Q36824388-6592D17D-DC75-4FBC-A630-9B693B67D510Q37002564-4C986A05-F701-4C49-86FD-C0C460E19B1FQ37661770-2414BD40-2185-4671-AEFB-7B4011415F2FQ38701493-1588823E-C9A5-447A-A00A-DCBEDCA9B320Q38754318-93777C3E-E5F7-4BCD-AECE-45C72923A7C0Q38936786-9664B53F-B2B7-4999-A208-FD854FBD93E6Q39768190-26F8950C-40D8-4EA0-BEA8-93ED601A047CQ40250340-ECA5C02C-92F5-46AB-B998-F575B4A29579Q40422107-3F5D2CF7-3310-4F2B-AEB2-7E74B403C40BQ41918728-0DFD7BEF-AC98-4A2D-8596-9B53A4EFD8DBQ41928841-0B2C7B11-321D-4F5A-B3E6-DB171DCFC542Q45874441-DEA44D14-20ED-4D67-8453-46D6C85EEE0FQ49920984-1B5B23E2-8F0F-4591-AA9A-4B59D440F560Q54242626-35927A03-14FF-4EF5-A684-F66DF696C9D2Q55278900-6D32542F-B41E-4496-A086-7368C4592885Q58085173-A4B36776-F883-43E7-8FD6-327FE421B809
P2860
A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A low HIV-DNA level in periphe ...... of maintaining viral control.
@en
type
label
A low HIV-DNA level in periphe ...... of maintaining viral control.
@en
prefLabel
A low HIV-DNA level in periphe ...... of maintaining viral control.
@en
P2093
P1433
P1476
A low HIV-DNA level in periphe ...... of maintaining viral control.
@en
P2093
ANRS 116 SALTO study group
Adeline Melard
Christophe Piketty
Lambert Assoumou
Laurence Weiss
Marianne Burgard
Pierre-Marie Girard
P304
P356
10.1097/QAD.0000000000000734
P407
P577
2015-09-01T00:00:00Z